NeueHealth, Inc. (NYSE:NEUE - Get Free Report) was the target of a significant decrease in short interest during the month of December. As of December 15th, there was short interest totalling 13,700 shares, a decrease of 48.9% from the November 30th total of 26,800 shares. Approximately 0.5% of the company's shares are short sold. Based on an average trading volume of 22,800 shares, the days-to-cover ratio is presently 0.6 days.
Insider Buying and Selling at NeueHealth
In other news, CEO George Lawrence Mikan III sold 16,803 shares of the firm's stock in a transaction that occurred on Tuesday, December 17th. The shares were sold at an average price of $4.18, for a total transaction of $70,236.54. Following the completion of the sale, the chief executive officer now owns 83,029 shares of the company's stock, valued at $347,061.22. This trade represents a 16.83 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Insiders own 64.30% of the company's stock.
Institutional Investors Weigh In On NeueHealth
Hedge funds have recently added to or reduced their stakes in the company. Pathway Capital Management LP bought a new position in shares of NeueHealth in the second quarter valued at $61,000. Renaissance Technologies LLC acquired a new stake in shares of NeueHealth in the 2nd quarter worth about $312,000. NEA Management Company LLC purchased a new position in shares of NeueHealth during the second quarter valued at approximately $14,834,000. Deer Management Co. LLC bought a new stake in NeueHealth during the second quarter worth $5,436,000. Finally, Partners Group Holding AG purchased a new stake in NeueHealth in the 3rd quarter valued at $463,000. Institutional investors and hedge funds own 63.88% of the company's stock.
Wall Street Analyst Weigh In
Separately, Royal Bank of Canada cut their target price on shares of NeueHealth from $8.00 to $7.00 and set a "sector perform" rating on the stock in a research note on Monday, December 9th.
Read Our Latest Analysis on NEUE
NeueHealth Price Performance
Shares of NEUE traded up $0.10 during trading hours on Friday, hitting $7.37. The stock had a trading volume of 72,398 shares, compared to its average volume of 21,593. NeueHealth has a 1-year low of $3.79 and a 1-year high of $16.59. The firm has a market capitalization of $61.06 million, a P/E ratio of -0.14 and a beta of 0.78. The firm has a 50 day simple moving average of $5.17 and a 200-day simple moving average of $5.28.
NeueHealth Company Profile
(
Get Free Report)
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
See Also
Before you consider NeueHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NeueHealth wasn't on the list.
While NeueHealth currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.